Aclaris Therapeutics
ACRS
ACRS
84 hedge funds and large institutions have $78M invested in Aclaris Therapeutics in 2019 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 33 increasing their positions, 27 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
66% less capital invested
Capital invested by funds: $227M → $78M (-$149M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $414K
Holders
84
Holding in Top 10
–
Calls
–
Puts
$414K
Top Buyers
| 1 | +$2.37M | |
| 2 | +$1.91M | |
| 3 | +$1.53M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$801K |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$718K |
Top Sellers
| 1 | -$12.2M | |
| 2 | -$4.18M | |
| 3 | -$2.59M | |
| 4 |
CIA
Capital Impact Advisors
Boston,
Massachusetts
|
-$1.39M |
| 5 |
BCP
Berylson Capital Partners
Boston,
Massachusetts
|
-$1.16M |